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GENE  COMPLEMENTATION 
Neither Ir-GL¢ Gene Need 
Be Present  in the Proliferative T  Cell to 
Generate an Immune  Response to Poly(Glu~SLys36pheg)n 
BY  DAN  L.  LONGO AND RONALD  H.  SCHWARTZ 
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, Bethesda, Maryland 20205 
The T  cell proliferative response to the synthetic polypeptide poly(Glu55Lysa6Pheg)n 
(GL~) 1 has been shown to be controlled by two separate immune response (Ir) genes, 
one mapping in the I-A  subregion,  the other in  the I-E/C subregion  (1).  Thus,  this 
system presented the possibility of analyzing in more detail the Ir gene control of the 
cell interactions required to generate a T  cell proliferative response. It was conceivable 
that one gene product was expressed in the antigen-presenting cell (APC), the other 
in the T  lymphocyte, and that both genes were required  for a  successful interaction. 
However, experiments involving radiation chimeras of the sort nonresponder parent 
A  (Pa) bone marrow plus nonresponder parent B  (Pb)  bone marrow transferred into 
lethally irradiated  complementing responder  (Pa  ×  Pb)F1  recipients  [P~ +  Pb ~  (P~ 
×  Pb)F1] demonstrated that at least one cell type had to express both gene products 
to  function  (2).  Further  experiments  involving  GL¢  presentation  by  nonimmune 
spleen  cells to primed T  lymphocytes from a  complementing responder  Fx  demon- 
strated that neither nonresponder parent  (Pa or Pb) possessed cells that could present 
GL~,  even  if both  types of spleen  cells  were  added  together,  whereas  (P,  ×  Pb)F1 
spleen cells could present GL¢ (2). These results suggested that the APC was one cell 
type, which had to express both Ir-GL~ gene products to generate an immune response 
tO GL~. 
In  this  paper,  we  examine  the  requirement  for  b  gene  expression  in  the  T 
lymphocyte. Knowing that  the APC had to express both b-GI~  gene products,  we 
transferred  Pa  +  Pb ---o (Pa  ×  Pb)F1  chimeric spleen  cells,  which  lack F1  APC,  into 
acutely irradiated  (Pa ×  Pb)F1 mice along with T  cell-depleted F1  bone marrow as a 
source of responder APC.  These mice responded  to GL~, which  demonstrates that 
both  Ir-GLdp  genes  do  not  have  to  be  present  in  the  T  lymphocyte  to  generate  a 
proliferative response to GL¢. 
Materials and Methods 
Animals.  C57BL/10(B10),  B10.A, and B10.A(5R) strains were purchased from The Jackson 
Laboratory,  Bar  Harbor,  Maine.  BI0.A(4R),  B10.A(18R),  (B10.A  X  B10)FI  [(A  X  B)F1], 
1  Abbreviations used in this paper." APC, antigen-presenting cell(s); ATS, anti-thymocyte serum; Con A, 
55  3~  9  concanavalin A; DNP, dinitrophenylated; GI~, poly(Glu Lys 'Phe )n; It, immune response; MHC, major 
histocompatibility complex; OVA, ovalbumin; Pa, nonresponder parent A; Pb, nonresponder parent B; 
PETLES, peritoneal exudatc T lymphocyte-enriched  cells; PPD, purified protein derivative  of Mycobacterium 
tuberculosis; RaMB, rabbit anti-mouse brain antiserum; (T,G)-A--L,  poly(Tyr,Glu)-poly  D,L-Ala--poly  Lys; 
TNP, trinitrophenyl. 
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(BI0.A[5R] × B10.A)F1 [(5R X A)F1], and (B10.A ×  B10.A[18R])F1  [(A ×  18R)F1] strains were 
bred in our own colony (Laboratory of Immunology, National Institutes of Health, Bethesda, 
Md.). Dr. Jack Stimpfling (McLaughlin Research Institute, Great Falls, Mont.) kindly provided 
some of the B10.A(18R)  and (B10.A ×  B10.A[18R])F1  animals. 
Radiation-induced Bone Marrow Chimeras.  Mice that had been given neomycin (2 g/liter) (The 
Upjohn Co., Kalamazoo, Mich.) and bacitracin (1 g/liter) (kindly provided by Dr. J. Small, 
Veterinary Resources Branch, National Institutes of Health) in their drinking water for 1 wk 
were exposed  to 900-950 R either at 126 R/min from a heavily filtered x-ray source, or 40 R/ 
rain from a cobalt source.  6-24 h after irradiation, animals were reconstituted with  l07 bone 
marrow cells administered by tail vein injection. The bone marrow had been harvested from 
animals treated with 0.6 cm  a of a  1  : 10 dilution of anti-thymocyte serum (ATS)  (lot  3-9225, 
Microbiological Associates, Walkersville, Md.) intraperitoneally 3 and 1 d before sacrifice and 
5 mg of cortisone acetate (The Upjohn Co.) intraperitoneaily  2 d before sacrifice. The harvested 
bone marrow was then treated in vitro by a two-step cytotoxicity method with 1 cm  a of a  1:40 
dilution of rabbit anti-mouse brain antiserum (RaMB)  per  10  s  cells  for  30  rain at  room 
temperature, followed  by excess guinea pig complement (4 mi of a  1:3 dilution). The RetMB 
was shown not to contain appreciable anti-stem-cell activity in a [l~I]iododeoxyuridine  spleen 
uptake assay (3). Bone marrow treated in this fashion had no demonstrable responsiveness to 
concanavalin A  (Con  A)  or  allogeneic stimulator cells.  Bone  marrow  recipients  had  no 
detectable Con A-responsive  cells in their spleens until day 15 post-reconstitution.  Reconstituted, 
irradiated mice were kept 12 wk before use, maintained on autoclaved food and bedding, and 
acidified water. Individual animals were H-2 typed in a  two-step microcytotoxicity assay on 
the day of experimentation. All chimeras had >90% of their spleen cells of donor origin, and, 
in the case of Pa +  Pb --~ FI animals, each parental type constituted between 30 and 70% of the 
spleen cells. 
T Cell Proliferation Assay.  T cells were purified from thioglycolate-induced  peritoneal exudate 
cells 14 d after immunization  by passage over nylon-wool columns, as previously described (4). 
Peritoneal exudate T  lymphocyte-enriched cells  (PETLES) were cultured in Click's medium 
that contained 10% fetal calf serum in round-bottom 96-well microtiter plates at  1-2 ×  l05 
3  cells/well in 0.2 cm  vol along with soluble antigen or antigen-pulsed APC (5). Stimulation was 
assessed at day 5 by measuring the incorporation of [aH]thymidine. The data are expressed  as 
arithmetic mean counts per minute =1= SEM, or as counts per minute change, the difference 
between the mean antigen-stimulated and medium control cultures. The Student's t test  was 
used to ascertain significant differences. 
Antigens  and  Immunizations.  Dinitropbenylated  (DNP)-ovalbumin  (OVA)  (DNP-OVA), 
which contained an average of seven DNP  groups per molecule of OVA, was prepared  as 
previously described  (5)  and  used  for  immunization at  10  #g/mouse and  in culture at  a 
concentration of  30  #g/ml.  Purified  protein  derivative  of Mycobacterium tuberculosis (PPD) 
(Connaught Medical Research Laboratory, Willowdale, Ontario) was used in culture at 20 #g/ 
ml. Pigeon cytochrome c was used for immunization  at 40 #g/mouse. Tobacco hornworm moth 
cytochrome c cyanogen bromide cleavage fragment 81-103 was used in culture at  10 #g/ml 
because  this  antigen elicits  a  heteroclitic  response  from  T  cells  immunized with  pigeon 
cytochrome c (6). Both cytochrome preparations were the gift  of Dr.  M.  Ultee and Dr.  E. 
Margoliash, Northwestern University, Evanston, Ill. The branched-chain synthetic amino acid 
polymer poly(Tyr,Glu)-poly D,L-Ala--poly Lys [(T,G)-A--L] (lot  MC6), originally purchased 
from Miles-Yeda (Rehovot, Israel) was the generous gift of Dr. Howard Dickler and Dr. Alfred 
Singer, Immunology Branch, National Cancer Institute, National Institutes of Health. It was 
used for immunization  at 50 #g/mouse and in culture at  100 #g/ml. GL~ was purchased from 
Miles-Yeda and was  the  generous gift  of Dr.  Alan  Rosenthal  (Merck  Sharpe  &  Dohme, 
Rahway, N. J.). It was used at 30 #g/mouse for immunization and 100 #g/ml in culture. All 
3  immunizations  were carried out in the hind footpads by injecting 0.1 cm  of an emulsion that 
contained a 1:1 mix of antigens in normal saline and complete Freund's  adjuvant that contained 
1 mg/ml of M.  tuberculosis strain H37Ra. 
Acute  Transfer Experiments.  Because  the  PETLES  assay  measures secondary  immune re- 
sponses, priming must be done in an environment  that provides responder APC. In F1 --~ parent 
chimeras, responder APC were found in the spleen and peritoneal cavity; thus, no transfer was 1454  T  CELL  IMMUNE  RESPONSE  PHENOTYPE  IS  ACQUIRED 
necessary.  However,  in  parent  ~  F1  chimeras,  responder  presenting  cells were  provided  for 
priming by transferring 107 T  cell-depleted F1 bone marrow cells together with 5 ×  107 chimeric 
spleen cells intravenously  into lethally irradiated  (900-950  R)  F1  hosts.  These  animals  were 
immunized on the day of adoptive transfer in the hind footpads with an emulsion of antigens 
and complete Freund's adjuvant.  T  cell proliferation was assayed  in a  PETLES population  2 
wk later. Some recipients had been thymectomized at 4-6 mo of age and were used 6 wk after 
thymectomy. 
Results 
Importance of Complete T  Cell Depletion  of Donor Marrow when Creating Radiation  Chi- 
meras.  Our  initial  studies  of the T  lymphocyte  proliferative  response  to  GI.4b  in  F~ 
---*  Pa  radiation  chimeras  suggested  that  there  was  little  or  no  host  restriction.  As 
shown in Fig.  1, when donor marrow was treated once with a  commercially available 
AKR  anti-C3H  ascites  (anti-Thy-1)  and  guinea  pig complement,  F1---* Pa chimeras 
rapidly  developed  a  detectable  proliferative  response  to  PPD  (4  wk)  and  pigeon 
cytochrome  c  (6  wk),  antigens  to  which  both  the  donor  and  host  are  responders. 
Surprisingly,  these chimeras  also rapidly  developed a  strong response  to GL~  (4 wk), 
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FiG.  1.  Antigen-specific  T  cell proliferation (Acpm)  is plotted against  weeks after bone marrow 
reconstitution  of lethally irradiated mice. All chimeras are F~ ---* Pa in which the donor is a responder 
to DNP-OVA, PPD, GI~, and pigeon cytochrome c and the recipient is a responder to DNP-OVA, 
PPD, and pigeon cytochrome c but a nonresponder to GI-4b. The group of chimeras represented by 
the dashed  lines (assayed  2-6 wk post-reconstitution)  were given bone marrow treated once with 
commercial anti-Thy-1.2.  Antigen-specific  T cells appeared 4-6 wk after reconstitution and were of 
donor Ir phenotype.  The group of chimeras represented by the solid  lines  (assayed 6-18 wk post- 
reconstitution)  were  given bone  marrow  rigorously  depleted  of T  cells  by  ATS, cortisone,  and 
RaMB treatment (Materials and Methods).  Antigen-specific  T cells emerged at 9-12 wk and were 
of host Ir phenotype. DAN L. LONGO AND RONALD H. SCHWARTZ  1455 
an antigen to which the donor, but not the host, is a responder. Such animals retained 
the same pattern of responsiveness for up to 15 too. To test the possibility that residual 
post-thymic T  cells in the donor marrow (7) rapidly expanded in the irradiated host 
to dominate the peripheral T  cell pool, anti-Thy-l-treated bone marrow was trans- 
ferred  into  adult-thymectomized,  lethally  irradiated  hosts.  When  some  of  these 
chimeras developed functional T  cells of donor Ir phenotype 6 wk after reconstitution 
(data not shown), more rigorous techniques of T  cell depletion of donor bone marrow 
were pursued. 
At least two types of T  lymphocytes are known to contaminate bone marrow cell 
preparations: one is the blood-borne, recirculating, long-lived T  cell that is sensitive 
to treatment with ATS (8); the second is the early post-thymic cell that is resistant to 
ATS  but  sensitive  to  cortisone  treatment  (9).  With  this  knowledge  in  mind,  we 
empirically devised a T  cell-depletion regimen by employing both ATS and cortisone 
treatment in vivo followed by RaMB treatment of the marrow cells in vitro (Materials 
and Methods). Such exhaustively depleted marrow from (5R ×  A)F1 mice was used 
to reconstitute lethally irradiated  B10.A mice and  their T  cells assayed at  varying 
times after reconstitution (Fig.  1). 
In  contrast  to  the  chimeras  created  with  only  anti-Thy-l-treated  marrow,  the 
chimeras created with exhaustively T  cell-depleted bone marrow showed no responses 
to any of the antigens tested at 6 wk. By 9 wk after reconstitution, the (5R ×  A) --* A 
T  cells gave a large proliferative response to the potent antigen DNP-OVA, a barely 
detectable response to pigeon cytochrome c, to which the B 10.A host is a responder, 
and no response to GI.~, to which the B10.A host is a  nonresponder. By  12 wk, the 
chimeras appeared to be completely reconstituted as indicated by the full response to 
the relatively weak immunogen, pigeon cytochrome c. Strikingly, no response to GL~ 
was evident, even as late as  18 wk after reconstitution. Thus, (5R ×  A)F1 stem cells, 
which in an isogeneic environment would develop into GI~ responder T  cells, failed 
to so develop when they matured in a  nonresponder environment, provided that the 
bone marrow was rigorously depleted of mature T  cells before transfer. 
These Ir-restricted, F1 --~ P  chimeras were also H-2 restricted in their response to 
antigens such as DNP-OVA  to which either parental  haplotype is a  responder. As 
shown in Fig. 1, (5R ×  A)FI --~ B10.A chimeras responded well to soluble DNP-OVA. 
However, when the antigen was presented to the chimeric T  cells on either B 10.A or 
B10.A(5R)  nonimmune  spleen  cells,  only  the  B10.A  spleen  cells  were  capable  of 
eliciting a significant proliferative response (Table I). The inability of the chimeric T 
cells  to  recognize DNP-OVA  in  association  with  B10.A(5R)  spleen  cells  was  not 
caused by a  failure to prime such cells as a  result of the absence of the appropriate 
presenting cells in the host. As shown in Table I, chimeric spleen cells were capable 
of presenting both GI~ and DNP-OVA to immune B10.A(5R) T  cells, thus demon- 
strating the presence of functional B10.A(5R)  restriction elements in these animals. 
Thus, the  failure of the  genotypic  (5R  x  A)F1 T  cells to recognize DNP-OVA  in 
association with B10.A(5R)  APC  suggested that  the T  cells had  become restricted 
during  their  development  in  the  B10.A  host  to  recognition  of only B10.A  major 
histocompatibility complex (MHC) products. 
T Cells from Pa  +  Pb ~  Ft Chimeras Behave Like F1 T  Cells when Primed in the Presence 
of Sufficient F1 APC.  B10.A and B10.A(18R)  marrow rigorously depleted of T  cells 
were given in equal amounts to lethally irradiated  (900-950 R)  (A ×  18R)F1 mice. 1456 
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When these A +  18R -* (A ×  18R)FI chimeras were immunized 12 wk or more after 
reconstitution (Table II, Exp.  1) good proliferative responses were observed to DNP- 
OVA, an antigen to which both parents can respond, (T,G)-A--L, an antigen to which 
only the 18R(/n) can respond, and pigeon cytochrome c, an antigen to which only the 
B10.A(/~) can respond. However, no response to GI.~ was seen. This confirmed our 
previous findings that the chimeras behavelike a mixture of the parental haplotypes 
and that the GLt  h response required the presence of at least one F1 cell type (2). Thus, 
rigorous depletion of T  cells from the donor marrow did not alter these conclusions. 
In A  +  18R --~  (A  ×  18R)F1 chimeras, the T  lymphocytes have developed in a 
responder F1 environment, but the APC, which derive from the donor bone marrow 
(see below), are of nonresponder parental origin. Our previous studies demonstrated 
the  requirement  for responder F1  presenting cells  to  generate  a  GI~  proliferative 
response (2). In an effort to provide them, chimeric spleen cells were transferred into 
an acutely irradiated (A ×  18R)F1, the adoptive recipient immunized immediately, 
and the PETLES response assayed 2 wk later in the presence of Fx APC in culture. As 
shown in Table II  (Exps. 2 and 3a), this adoptive transfer resulted in a  very small 
response to GL~. However, compared with the large responses to DNP-OVA,  (T,G)- 
A--L, and especially the weaker antigen, pigeon cytochrome c, the response to GLth 
had to be considered marginal at best. However, when the phenotype of the splenic 
APC of the adoptive recipients was assayed 2 wk after transfer, no cells capable of 
presenting  GL~  to  immune  F1  T  cells  were  found  (data  not  shown).  This  result 
suggested that the turnover of the APC in the spleen of lethally irradiated mice must 
be more rapid than 2 wk and raised the possibility that the failure of the chimeric T 
cells to respond well to GL~ when transferred into the acutely irradiated second host 
was because of an inadequate number of responder APC for priming and not because 
of an intrinsic lr gene defect in the T  cell. 
To examine this question, spleen cells and peritoneal washings obtained by lavage 
of the peritoneal cavity from normal  and  irradiated  BI0 mice were compared  for 
their ability to present DNP-OVA to syngeneic immune T  cells. Mice were irradiated 
with 900-950 R  at varying times before assay. The results are depicted graphically in 
Fig. 2 with the left panel showing presentation by spleen cells and the right showing 
presentation by cells in peritoneal washings.  The figure shows that  as early as 2  h 
after 900-950  R,  a  decrease  in  the  ability  of spleen  cells  to  present  antigen  was 
observed, and  no antigen presentation above allogeneic controls was  detectable by 
day 4 after irradiation in all eight experiments in which it has been tested. Mixing 
irradiated and normal spleen populations did not inhibit antigen presentation, thus 
ruling out nonspecific suppression as an explanation. In animals not reconstituted by 
hemopoietic stem cells, assaying spleens for APC  as late as day 8  after irradiation 
revealed no return of antigen presenting activity, which suggested that the disappear- 
ance was not transient. 
Fig. 3 reveals the effect of reconstituting irradiated mice with T  cell-depleted bone 
marrow on the reappearance of APC activity. Three types of radiation chimeras were 
created:  B10 --~  B10.A(3R),  B10.A(3R) --~  BI0, and  B10.A -~ B10. Both BI0 and 
B10.A(3R) animals possess  I-A b alleles, and, therefore, spleen cells from both strains 
of mice should  present  DNP-OVA  to  immune T  cells recognizing IoA b.  In  Fig.  3 
(panel A), the spleen cells from B10 --~ B10.A(3R) and BI0.A(3R) --~ B10 chimeras 
4  d  after irradiation  and  reconstitution were compared with  B10, B10.A(3R),  and 1458  T  CELL  IMMUNE  RESPONSE  PHENOTYPE  IS  ACQUIRED 
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Fro.  2.  Antigen-specific T  cell  proliferation  (Acpm)  of DNP-OVA-immune PETLES  from  B10 
mice in response to DNP-OVA-pulsed spleen cells in panel A, and in response to DNP-OVA-pulsed 
peritoneal washings in panel B  are plotted against the log of cell  number. Spleen  and peritoneal 
cells  from  B10  animals at  various  times after  (~)  receiving  900  R  are  compared  with  normal 
syngeneic and allogeneic controls for their ability to present antigen. 2 h  after 900 R, both spleen 
and peritoneal cells were about one-half as efficient at  antigen presentation as unirradiated  cells, 
and, by 24 h after 900 R, antigen presentation was only slightly better than allogeneic cells. 
allogenic B 10.A spleens for their ability to present DNP-OVA to B 10.A(3R)-immune 
PETLES.  Both types of chimeras and BI0 and B10.A(3R)  spleen cells all initiated  a 
proliferative response  to  DNP-OVA,  whereas  the  allogeneic  B10.A  spleen  cells  did 
not. This suggests that the injection of a proliferating stem-cell pool into the irradiated 
mice reversed the loss of presenting activity in the spleen at 4 d  after irradiation.  In 
Fig. 3 (panel B), the ability of the B10.A(3R) ---* BI0 and B10--o BI0.A(3R) chimeric 
spleen  cells  to  present  GL~  to  B10.A(3R)  PETLES  was  compared  with  B10  and 
B10.A(3R)  spleen  cells.  B10.A(3R)  spleen  cells  possess  both  /r-GL4,  genes  (one 
mapping in LA b the other in LEk/C a) and, unlike the low-responder B10 cells, will 
present GLq, to immune responder T  cells. Thus, B10 ~  BI0.A(3R)  and B10.A(3R) 
B10 chimeras should enable us to determine unambiguously whether the APC in 
the spleen of irradiated mice is repopulated by radioresistant host APC from another 
site or by donor bone marrow stem cells. The data show that the B10.A(3R) --~ B10 
spleen cells could present GL~ and therefore were of donor marrow origin. The B 10 
--* B10.A(3R)  spleen cells behaved like B10 cells (panel  B), being unable to present 
GI_~, although  they did present  DNP-OVA well  (panel  A);  this demonstrated  that 
the hosts APC do not survive to repopulate the spleen. 
B10.A ---* B10  chimeras were created  to  determine  whether  the  results  with  B10 
---* B10.A(3R)  and B10.A(3R)  ---* B10 chimeras were a  result of the fact that  donors 
and recipients were I-A compatible. If rapid APC reconstitution  from donor marrow 
was a result of an I-A region-dependent cell trafficking, B 10.A----) B l0 antigen-pulsed 
spleen  cells  might  not  generate  proliferative  responses  in  B10.A  T  cells.  In  Fig.  3 DAN L.  LONGO AND RONALD  H.  SCHWARTZ  1459 
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Fro. 3.  In panel A, the proliferative response (Acpm) of B10.A(3R) DNP-OVA-immune  PETLES 
to DNP-OVA-pulsed spleen cells are plotted against cell number. Antigen-pulsed spleen cells from 
B10, BI0.A(3R), and BI0.A are compared with spleen cells from B10.A(3R) ~  Bl0 and B10 --* 
B10.A(3R) chimeras 4 d after reconstitution. The chimeras were nearly as effective as the parental 
BI0.A(3R) and Bl0 at presenting DNP-OVA. In panel B, the proliferative response of GI.~-immune 
PETLES  to  GI.,~pulsed spleen  cells are plotted against  cell  number.  BI0.A(3R)  spleen  cells 
presented GI~, as did B 10.A(3R) --* B 10 chimeric spleen cells, whereas B 10 and B l0-* B 10.A(3R) 
did not. In the chimeras, the presenting cell phenotype was that of the donor bone  marrow. In 
panel C, the ability of BI0.A --* Bl0 chimeric spleen cells to present DNP-OVA  to B10.A DNP- 
OVA-immune PETLES is shown. Again, the chimeric spleen cells were of donor phenotype. 
(panel C),  this issue is resolved by the data that  show  that  B10.A ~  B10  chimeric 
spleen cells successfully presented DNP-OVA to B 10.A T  cells 4 d after reconstitution, 
although they failed to present to B 10.A(3R) T  cells (data not shown). Thus, even in 
allogeneic  chimeras,  the  experiments  suggested  that  the  APC  in  the  spleen  and 
peritoneal cavity disappear within 4 d after lethal irradiation and are rapidly replaced 
by APC from the reconstituting bone marrow. 
This rapid turnover of peripheral APC could have been responsible for the apparent 
low  responsiveness  to  GI~  of A  +  18R  ---* (A  X  18R)F1  chimeric  T  cells  in  the 
adoptive host.  If adequate  numbers  of F1  presenting cells were  not  present  in  the 
priming environment,  then  secondary  in  vitro responses  (as in  the  PETLES  assay) 
might not have been detectable. Therefore, to eliminate this potential reason for low 
responsiveness, we repeated the adoptive transfer ofA +  18R ~  (A ×  18R)F1 chimeric 
spleen  cells into  irradiated  (A  X  18R)Fa  animals  and  added T  cell-depleted (A  X 
18R)FI bone marrow as a source of responder APC. The results of this experiment are 
shown in Table II (exp. 3). The presence of the T  cell-depleted Ft bone marrow in the 
adoptive host enabled the chimeric T  cells to manifest a proliferative response to GI_~ 
(Table II, line 3b)  in addition to responding to DNP-OVA,  (T,G)-A--L, and pigeon 
cytochrome c as seen before. To assure that the T  cell-depleted F~ bone marrow cells 
were  not  providing the T  cells that  were responding to the GI~,  the bone marrow 
was  transferred  alone  into  irradiated  F1  mice.  As  shown  in  Table  II  (line  3c),  no 
antigen-responsive T  cells were detected. These results suggest that both Ir-GI_~ genes 
do not have  to be expressed in the T  cell to generate an  immune response to Gl.zh, 
provided  that  the  T  cells  mature  in  a  responder  environment  and  that  they  are 1460  T CELL IMMUNE RESPONSE PHENOTYPE IS ACQUIRED 
primed to the antigen in a  host with sufficient responder APC. 
Although  the  T  cell-depleted  F1  bone  marrow  seemed  not  to  be  a  source  of 
responding T cells, it was possible that in the presence of mature spleen cells from the 
chimera that F1 stem cells could more rapidly differentiate into functional T  cells. To 
rule out this possibility, nonresponder B10.A(18R) spleen cells  were transferred  into 
irradiated  (A X  18R)F1  mice along with T  cell-depleted F1 bone marrow. As shown 
in Table II (line  4b),  the adoptively transferred  mature B10.A(18R)  splenic T  cells 
retained their MHC-dictated pattern of responsiveness showing proliferation to DNP- 
OVA and  (T,G)-A--L but no response to GL4, and pigeon cytochrome c. Finally, to 
unequivocally rule out the possibility of an F~ stem cell rapidly differentiating into a 
GL4-responder T  cell, we performed adult thymectomy on (A X  18R)F1 animals and 
used them as adoptive hosts 6 wk later. A +  18R --+ (A X  18R)F1 chimeric spleen cells 
plus T  cell-depleted F1 bone marrow transferred into thymectornized, lethally irradi- 
ated F1 animals showed responsiveness to all four antigens, DNP-OVA, (T,G)-A--L, 
pigeon cytochrome c, and GIx~ as shown in Table II (Exp. 5). Therefore, the adoptive 
host's thymus does not seem to play a  role in the appearance of GL~ responsiveness 
in these animals. 
Thus, A +  18R ~  (A X  18R)F1  chimeras behaved as a  mixture of H-2  ~ and H-2  b 
cells  until  they were  primed  to  antigen  in  an  environment  providing adequate  F1 
APC. Once this requirement  was met, a  phenotypic alteration  could be detected  in 
these  parental  T  cells  that  had  matured  in  an  F1  environment.  They appeared  to 
have learned to respond to antigen in the context of F1 H-2 restriction elements. 
A  Two  T  Cell Model for Gene Complementation.  The development of GIx~-responsive 
T  cells  in A  +  18R ~  (A X  18R)F1  chimerals could mean that T  cells  possessing a 
responder allele at either I-A  or I-E/C can develop the recognition structure  for the 
unique F~ restriction element when they mature in an F~ environment. However, an 
alternative  explanation  for  the  data  suggested  to  us  by  Dr.  Alfred  Singer  is  that 
tolerance induction in the chimera allows the H-2" and//-2  b donor T  cells to interact 
without a mixed-lymphocyte reaction. In the F1 Gix~ responder, one T cell specific for 
LA b plus GLq~ and one T  cell specific for I-E~/C  d plus GL~ might interact to make an 
immune response only when GL~ is presented on an FI (LA b, I-E~/C a)  APC, which 
brings the two T  cells  together. Similarly, in the chimera with/-/-2  ~ and H-2  b T  cells 
tolerant to each other, the GI~ response is revealed when F~ APC are provided. To 
test this hypothesis, we made (A ×  B)F1 ~  B 10.A chimeras that were restricted to H- 
2  ~ responses  (DNP-OVA and pigeon cytochrome c responders)  and  (A ×  B) --+ B 10 
chimeras that were restricted to H-2  b responses [DNP-OVA and (T,G)-A--L respond- 
ers].  Neither type of chimera responded to GI~ (see Table IV). If two interacting T 
cells are required for a GI-  4, response, one specific for LA b plus GI_~ and one specific 
for I-Ek/C a plus GL~, then (A ×  B)F1 --+ B chimeric T  cells could provide the former 
and (A ×  B)Fa ~  A chimeric T  cells  the latter. Therefore, we mixed (A X B)F1 ~  A 
and  (A  ×  B)F1 --~  B  chimeric  spleen  cells,  administered  them  intravenously  to 
irradiated  (A  ×  B)F1 mice,  immunized  them  in  the  footpads,  and  assayed  their 
PETLES 2 wk later. The results of this experiment are shown in the last line of Table 
III. The proliferation to DNP-OVA, (T,G)-A--L, and pigeon cytochrome c revealed 
the successful generation of a  mixture of H-2  a and H-2  b specific T  cells;  however, no 
response to GL  4, was observed. This was strong evidence against a  two T  cell model 
for gene complementation in the GL~ response and supported the interpretation that DAN L. LONGO AND RONALD H. SCHWARTZ 
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Source of PETLES 
Proliferative response (cpm ±  SEM) to 
Medium  DNP-OVA  GI~  Cr,G)-A--L  Pigeon cytochrome c 
A x  B---* A  2,231 +  243  69~61~2 :l: 5,449  2,181 :t: 196  2,466 +  290  23,448 -4- 931 
A X B --* B  1,586 -I- 329  511227 +  4,820  1,721  :t: 83  39~754 +  3,469  1,231:1:296 
(A ×  B ~  A)  +  (A ×  B --, B)  3,561 +  104  52~771 +  3,414  4,639 :t: 507  57r753 ±  1,613  31r478 :1:1,247 
--*A× B 
Underlined values are statistically significantly different from the medium control.  (A ×  B)Ft bone marrow was given to lethally irradiated 
parental mice, and their antigen responsiveness was tested in the PETLES assay 3 mo later. Spleen cells from A  ×  B ---* A and A  ×  B --* B 
chimer~J-s were mixed and given to lethally irradiated (A ×  B)FI mice. These mice were immunized, and their PETLES were assayed 2 wk later. 
TABLE IV 
Neither Ir-Gl_4b Responder Allele Need Be Present in the T Cell 
Line  Source of PETLES 
Proliferative response (cpm ±  SEM) to 
Medium  DNP-OVA  GL~  (T,G)-A--L  Pigeon cytochrome c 
a  4R---~  A ×  18R  1,796:1:211  511819:1:4,484  1,664+199  2,009:1:312  1,982±368 
b  (4R ~  A  ×  ISR) spleen +  -T (A  519 -l- 97  34r890 -t- 4,053  27t268 ±  3,775  28r588 +  807  12~224 ±  1,439 
×  18R) BM ~  A ×  18R 
c  -T (A ×  18R) BM ~  A ×  IBR  800 +  1130  800 ±  100  700 -I- 100 
The designation "-T" means T  cell depleted. "BM" means bone marrow.  Underlined values are significantly different  from  the medium  control by 
Student's t test. BI0.A(4R) bone marrow was used to reconstitute lethally irradiated (A X  IBR)FI mice, and these animals had their T  cell responses 
measured by PETLES assay (line a) or donated spleen cells to acutely irradiated adoptive (A ×  18R)F] hosts that also received T cell-depleted Fl bone 
marrow (line b). Some adoptive hosts received T  cell-depleted bone marrow only (llne c). The adoptive Fl hosts were immunized on the day of transfer, 
and their T  cells were assayed 2 wk later. 
in Pa +  Pb ~  F1 chimeras a  population of T  cells is generated whose repertoire has 
been expanded to recognize Fl-specific structures on APC. 
The  results  of this  experiment  also  bear  on  the  mechanism  by  which  F1  ---* P 
chimeras develop T  cells restricted to host haplotype-specific interactions. It could be 
argued that the restriction of FI ~  Pa to H-2  ~ phenotype responses is a manisfestation 
of suppression of all H-2~-reactive clones. If suppression were the explanation for the 
acquired H-2 restriction, then each subpopulation of T  cells in (Fx ---* A) and (F1 ---* 
B) mice should have suppressed the other in the mixing experiment and no antigen- 
specific proliferation should have been seen. The fact that T  cells from these animals 
behaved like mixtures of H-2  ~ and H-_-  d' T  cells makes suppression  a  most unlikely 
explanation for thymic restriction. 
Neither Responder Allele Need Be Present  in the T  Cell  The Gl_4b responsiveness of A 
+  18R ----> (A ×  18R)Fa T  cells suggested that both gene products did not have to be 
expressed in the T  cell. However, because each parental T  cell possesses one of the lr- 
GI.4b genes, it was possible that a responder T  cell had to express one or the other b- 
GI.4b gene product.  To test  this possibility we turned  to the B10.A(4R)  strain  that 
possesses neither responder Ir-Gl.@ allele. In addition this strain is a  nonresponder to 
pigeon cytochrome c and  (T,G)-A--L. T  cell-depleted B 10.A(4R)  bone marrow cells 
were transferred to lethally irradiated  (A ×  18R)Fa recipients, and the chimeras were 
immunized 3 mo later. As shown in Table IV, 4R ---* (A X  18R)Fa chimeras, which 
have  4R-type  APC,  showed  a  proliferative  response  to  DNP-OVA  but  did  not 
proliferate in response to any antigens to which 4R is a nonresponder (Table IV, line 
a).  However, when  4R ---* (A X  18R)F1  chimeric spleen cells were transferred  into 1462  T  CELL  IMMUNE  RESPONSE  PHENOTYPE  IS  ACQUIRED 
irradiated (A ×  18R)F1  mice along with T  cell-depleted F1 bone marrow (Table IV, 
line b) good proliferative responses to DNP-OVA,  (T,G)-A--L, pigeon cytochrome c, 
and GI~ were seen. F1 bone marrow alone did not produce responsiveness to any of 
these antigens  (Table IV, line c). Thus, the B10.A(4R)  cells acquired the ability to 
manifest responses in both one- and  two-gene controlled systems by maturing in a 
responder  environment.  It  is  clear  from  the  results  of this  experiment  that  low 
responsiveness is not an intrinsic property ofT cells bearing low-responder alleles, but 
is a phenotype that can be altered. Thus, for GL~, neither Ir gene need be present in 
the T  cell to mount a proliferative response. 
Discussion 
The mechanism  of H-2 restriction and  Ir gene control has been  under intensive 
investigation in many laboratories. Recently, experiments done with animals manip- 
ulated such that they contain cells of differing genotypes (chimeras) have shed light 
on the process by which T  cell precursors acquire self recognition. Zinkernagel  (7) 
demonstrated  that  cytotoxic cells of (Pa  ×  Pb)F~ genotype that  had  matured  in  a 
parental  (Pa) environment were restricted to lysing virus-infected targets displaying 
K ~ or D a. Despite their genotype, no cells with anti-K  b or anti-D  b plus virus specificity 
could be demonstrated, and control experiments (10) suggested that suppression could 
not explain the failure to detect such cells.  Furthermore, genotypic Pa cytotoxic cells 
that had developed in a  (Pa ×  Pb)F1 environment acquired specificity to iyse virus- 
infected targets displaying K b and/or D b in addition to/~  and D a targets; however, 
this  could  only  be  demonstrated  when  the  chimeric  cells  were  sensitized  in  an 
irradiated F1 host (7). Thymic transplant experiments suggested that the thymus was 
responsible  for altering  the  phenotype of the  maturing  T  cells  (7,  11,  12). These 
seminal observations have been extended to systems measuring transplantation across 
minor histocompatibility barriers (12), male-specific killing (13), delayed-type hyper- 
sensitivity (14), helper T  activity (12,  15-20), trinitrophenyl (TNP)-modified target 
cytotoxicity (21,  22), and, in this report, T  cell proliferation. 
The simultaneous alteration of H-2 restriction and Ir phenotype of helper T  cells 
by the developmental environment has been reported in systems measuring antibody 
responses.  Kappler and  Marrack  (17)  found that  (A  ×  B)F1 ~  A  (low responder) 
chimeric  helper  T  cells  could  not  support  a  secondary  TNP-(T,G)-A--L-specific 
plaque-forming cell response and were unable to cooperate with B parent's macro- 
phages and B cells. The loss of responsiveness paralleled the loss of capacity to interact 
with H-2 products of the responder Ir genotype. The site of this Ir restriction of the T 
cell  was  shown  to  be  the  thymus  by  Hedrick  and  Watson  (23)  for  a  secondary 
antibody response to calf skin collagen in F1 --+ nonresponder thymus chimeras. For 
chimeras of the type A(low-responder) ~  (A ×  B)FI Kappler and  Marrack  (17)  as 
well as Hodes et al.  (24)  found that  P~ chimeric T  cells could help Pb macrophages 
and B cells to produce a  secondary or primary anti-TNP-(T,G)-A--L response.  But 
these P~ chimeric T  cells could not convert P~ macrophages to responder phenotype 
(24).  Thus,  the  T  cell phenotype was  altered  by relaxing its  genetic  restriction  to 
interact with cells expressing H-2  b gene products. Similar results have been obtained 
in cytotoxic systems (7,  13, 22, 25). 
We  have extended these observations  to  the  proliferative T  cell  and  have  used 
chimeric animals  to examine  the  mechanism  of gene complementation  in  antigen DAN L. LONGO AND RONALD H. SCHWARTZ  1463 
responses under dual Ir gene control. Similar to other workers who used one-gene 
systems, we have found that  responder (Pa  ×  Pb)Fx genotype T  cells maturing in a 
nonresponder  Pa  environment  are  nonresponders  to  antigens  to  which  parent  Pb 
genotype cells  should  respond  (Table  III).  Furthermore,  the  non-Ir-controlled re- 
sponses  of the  chimeric T  ceils  to  antigens  such  as  DNP-OVA  are  only through 
interactions with host-MHC-bearing APC  (Table I). Thus, F1 ~  P, chimeric T  cells 
lost  from their repertoire the capacity to interact with  Pb APC.  For dual lr gene- 
controlled responses, T  cell development in either parental  environment led to the 
loss  of GL~ responsiveness (Table III). Even mixtures of the two types of chimeric 
cells, F1 ~  A and F1 ~  B, could not overcome this defect (Table III). It would appear 
from these experiments that  in  all  cases T  cells  must  mature  in  a  high-responder 
environment to respond to the antigen. For Gl-,th, the high-responder environment is 
only that of the F1. 
The nonresponsiveness to Gl-zh of A  +  B ~  (A ×  B)Fx chimeric T  cells primed in 
the chimera demonstrated that in addition to having T  cells mature in a  responder 
environment at least one cell type participating in the proliferative response had to 
express both Ir-Gl_~ genes, i.e., come from a  responder donor (Table II)  (2).  When 
these chimeric T  cells were primed in an environment that provided responder APC, 
the T  cells were capable of proliferating in response to GI~, which showed that both 
lr-Gl_~ genes have to be present in the APC but not in the T  lymphocyte (Table II). 
The finding that B10.A(4R) ~  (A ×  B)Fx chimeric T  cells responded to GI~ when 
primed with responder APC showed that neither Ir-GI.,dp gene need be present in the 
T  cell (Table IV). Therefore, both complementing lr-GI~ genes must be expressed in 
the  APC  and  neither  need  be  in  the  T  cell  as  long  as  it  has  developed  in  an 
environment  in  which  both  genes  are  present.  These  data  support  the  concept 
emerging from the two-dimensional gel studies of  Jones et al. (26), the Ia-sequencing 
studies of Cook et al.  (27)  and Silver (28), and our studies  (29)  of complementation 
for APC  function by strains bearing Ia.7  ÷ 1-E/C gene products, that  gene comple- 
mentation involves the pairing of an 1-E/C-encoded  a-chain with an/-A-encoded fl- 
chain to form a  single two-chain-restricting element. Thus, complementation occurs 
at  the  level of a  single  cell  (APC)  by post-translational  assembly of the  two gene 
products, not by cooperation between two cells each expressing one responder allele. 
An acutely irradiated Fradoptive host has been shown to be an adequate source of 
F1 APC for helper T  cell priming by Sprent (15)  although not by Waldmann et al. 
(30). For priming the proliferative T  cell, whose secondary response is assayed at least 
14 d after priming, this simple adoptive transfer was found not to be adequate. The 
rapid disappearance of peripheral APC required the addition of T  cell-depleted bone 
marrow to provide sufficient presenting cells to prime the proliferating T  lymphocyte. 
It is possible that the success of the adoptive host in providing APC for priming the 
helper T cell achieved by some workers represents a kinetic difference in requirements 
for priming different T  cell subsets. Alternatively, it may be necessary to reexamine 
conclusions obtained from such experiments in light of the possibility that the only 
source of functional APC may be in the donor cell population. 
Our findings on the rapid turnover of peripheral APC after irradiation raise some 
additional  questions on the nature and  function of this cell type. For example, we 
have  no  explanation  for  the  finding  that  the  splenic  and  peritoneal  APC  are 
radiosensitive in vivo but function well after in vitro irradiation (5). Furthermore, the 1464  T  CELL  IMMUNE  RESPONSE  PHENOTYPE  IS  ACQUIRED 
splenic APC may be different from cells with the same function in the liver (Kiipffer 
cells)  (31), skin  (Langerhans cells)  (32), and thymus (33).  The turnover of the latter 
two types of APC after radiation has recently been shown to be slower than that of 
the splenic APC (34,  35)  (D. L. Longo and R. H. Schwartz. Manuscript  in prepara- 
tion.). Differences in rates of turnover of the cell in different sites may be important. 
In particular, our recent discovery of the slow turnover of the APC in the thymus is 
interesting because a parsimonious theory of H-2 restriction could be advanced if the 
thymic APC could be demonstrated to play an important role in the development of 
self-recognition in the thymus. 
The  results  of others  (7,  13,  17,  22-25)  in  one-gene  Ir-controlled  systems  taken 
together with the data presented in this paper on one-gene and complementing two- 
gene Ir-controlled systems lead to the conclusion that at least one class of Ir genes is 
expressed in the APC. An Ir-controlled response can be initiated by these cells in any 
T  cell capable of interacting with this Ir gene product. These responder T  cells can be 
genotypic responders or genotypic nonresponders that have matured in a  responder 
environment. If the T cells matured in a nonresponder environment, they were unable 
to  be stimulated  to  make Ir-controlled  responses  because  they appear not  to  have 
acquired the ability to interact with responder gene products on the APC. To date, 
Ir gene control  and  H-2 restriction  of immune responses have not  been  separable. 
Thus, the Ir gene product and the H-2-restricting element may be the same structure 
(7, 36). 
Summary 
The cellular  requirements  for immune  response  (Ir) gene expression  in  a~T  cell 
proliferative  response  under  dual  Ir  gene  control  were  examined  with  radiation- 
induced bone marrow chimeras. The response to poly(Glu55Lys36Pheg)n (GL~) requires 
two responder alleles that in the [B10.A ×  BI0.A(18R)]F1  map in LA b and I-Ek/C d. 
Chimeras in which a mixture of the nonresponder B 10.A parental cells (which possess 
only I-Ek/C a) and the nonresponder B 10.A(18R)  parental cells (which possess only/- 
A  b) were allowed to mature in a responder F1 environment did not respond to GL~, 
which suggests that at least one cell participating in  the response needed  to possess 
both responder alleles to function. When T  cells from such A  +  18R ~  F1 chimeras 
were primed in the presence of responder antigen-presenting cells (APC), the chimeric 
T cells responded to GI_4, which suggests that both responder alleles must be expressed 
in  the  APC  but  not  necessarily  in  the  T  cell.  Interestingly,  acutely  irradiated  F1 
animals were found not to be an adequate source of responder APC for priming the 
proliferating T  cell because of the rapid turnover of peripheral APC after irradiation. 
In adoptive transfer experiments, T  cell-depleted bone marrow had  to be used as a 
source of responder APC. 
When bone marrow cells from (B 10.A ×  B 10)Fa responder animals were allowed to 
mature in a  low-responder B10 or B10.A parental environment, neither chimera, F1 
--~ A or F1 --* B, could respond to GL~. This demonstrated that the presence of high- 
responder  APC,  which  derive  from  the  donor  bone  marrow,  was  not  sufficient  to 
generate  a  GI_~  response.  It  appears  that  in  addition  it  is  essential  for  the  T 
lymphocytes to mature in a high-responder environment. Finally, B 10.A(4R)  T  cells, 
which  possess neither Ir-GL~ responder allele, could  be educated  to mount  a  GI~- 
proliferative response provided that  they matured  in  a  responder environment  and DAN L. LONGO AND RONALD H.  SCHWARTZ  1465 
were primed with APC expressing both responder alleles. Therefore, the gene products 
of the complementing Ir-GI~ responder alleles appear to function as a  single restric- 
tion element at the level of the APC. T  cells that do not possess responder alleles are 
not intrinsically defective, because they could be made phenotypic responders if they 
developed in an environment  in which responder major histocompatibility  complex 
(MHC)  products were learned as self and if antigen was presented  to them by APC 
expressing responder MHC  products. 
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